United Press InternationalImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




STDs increase HIV risk if exposed

United Press International - September 9, 2008


AMSTERDAM, Netherlands, Sept. 9 (UPI) -- People with genital herpes, gonorrhea, syphilis and chlamydia have an increased risk of being infected if exposed to HIV, Dutch researchers warn.

Teunis B.H. Geijtenbeek and colleagues at VU University Medical Center in Amsterdam said a way in which STDs can increase acquisition of HIV-1 infection in an ex vivo human skin explant -- isolation of cells from a piece of tissue.

In the ex vivo human skin explant model, although immature immune cells known as Langerhans cells captured HIV, they did not efficiently transmit the virus to T cells -- a group of white blood cells known as lymphocytes involved with immunity -- something that is essential for the initiation of full disease.

By contrast, efficient virus transmission was observed if Langerhans cells were activated by inflammatory stimuli. As the infectious agents that cause the STDs thrush and gonorrhea triggered the same inflammatory stimuli in vaginal and skin explants, the authors suggest that in the presence of an STD-causing infectious agent, Langerhans cells might become activated, thereby increasing an individual's risk of becoming infected with HIV.

Further, these data suggest anti-inflammatory therapies might provide a way to prevent HIV transmission, the researchers said.

The findings are published in the Journal of Clinical Investigation.


080909
UP080907


Copyright © 2008 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .